Nuwellis, Inc. (NUWE)
0.7878
+0.01
(+0.88%)
USD |
NASDAQ |
Sep 08, 16:00
0.8099
+0.02
(+2.81%)
Pre-Market: 08:37
Nuwellis Shareholders Equity (Quarterly) : -2.045M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.045M |
| March 31, 2026 | 2.669M |
| December 31, 2025 | 2.63M |
| September 30, 2025 | 3.914M |
| June 30, 2025 | -8.955M |
| March 31, 2025 | 3.582M |
| December 31, 2024 | 6.53M |
| September 30, 2024 | 3.179M |
| June 30, 2024 | -6.834M |
| March 31, 2024 | 0.887M |
| December 31, 2023 | 3.211M |
| September 30, 2023 | 7.839M |
| June 30, 2023 | 11.07M |
| March 31, 2023 | 13.66M |
| December 31, 2022 | 12.36M |
| September 30, 2022 | 14.02M |
| June 30, 2022 | 17.66M |
| March 31, 2022 | 21.71M |
| December 31, 2021 | 25.95M |
| September 30, 2021 | 29.98M |
| June 30, 2021 | 26.00M |
| March 31, 2021 | 30.35M |
| December 31, 2020 | 16.32M |
| September 30, 2020 | 20.33M |
| June 30, 2020 | 9.602M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.704M |
| December 31, 2019 | 1.99M |
| September 30, 2019 | 4.338M |
| June 30, 2019 | 8.434M |
| March 31, 2019 | 12.53M |
| December 31, 2018 | 5.936M |
| September 30, 2018 | 9.653M |
| June 30, 2018 | 8.809M |
| March 31, 2018 | 12.39M |
| December 31, 2017 | 16.24M |
| September 30, 2017 | 6.981M |
| June 30, 2017 | 9.505M |
| March 31, 2017 | 3.852M |
| December 31, 2016 | 2.242M |
| September 30, 2016 | 2.46M |
| June 30, 2016 | 3.689M |
| March 31, 2016 | 7.612M |
| December 31, 2015 | 12.17M |
| September 30, 2015 | 18.44M |
| June 30, 2015 | 24.52M |
| March 31, 2015 | 30.07M |
| December 31, 2014 | 29.22M |
| September 30, 2014 | 35.06M |
| June 30, 2014 | 40.52M |
| March 31, 2014 | 46.21M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GlucoTrack, Inc. | -1.741M |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.126M |
| Total Liabilities (Quarterly) | 11.17M |
| Debt to Equity Ratio | -0.0978 |
| Current Ratio | 1.971 |
| Net Debt Paydown Yield | 3.33% |